{"id":"https://openalex.org/W1998391237","doi":"https://doi.org/10.1158/1538-7445.am2013-3532a","title":"Abstract 3532A: Development of gene therapy for pancreatic carcinoma: from experimental models to phase I clinical trial.","display_name":"Abstract 3532A: Development of gene therapy for pancreatic carcinoma: from experimental models to phase I clinical trial.","publication_year":2013,"publication_date":"2013-04-01","ids":{"openalex":"https://openalex.org/W1998391237","doi":"https://doi.org/10.1158/1538-7445.am2013-3532a","mag":"1998391237"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2013-3532a","doi":"https://doi.org/10.1158/1538-7445.am2013-3532a","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-3532a","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077103144","display_name":"Louis Buscail","orcid":"https://orcid.org/0000-0003-4276-1003","observed_orcids":["https://orcid.org/0000-0003-4276-1003"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Louis Buscail","raw_affiliation_strings":["1Toulouse Hospital and INSERM, Toulouse, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Toulouse Hospital and INSERM, Toulouse, France;","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064519018","display_name":"Barbara Bournet","orcid":"https://orcid.org/0000-0002-3679-9454","observed_orcids":["https://orcid.org/0000-0002-3679-9454"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Barbara Bournet","raw_affiliation_strings":["1Toulouse Hospital and INSERM, Toulouse, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Toulouse Hospital and INSERM, Toulouse, France;","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012560255","display_name":"Fabienne Vernejoul","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142058","display_name":"InvivoGen (France)","ror":"https://ror.org/03fdne361","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210142058"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fabienne Vernejoul","raw_affiliation_strings":["2Cayla INVIVOGEN, Toulouse, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cayla INVIVOGEN, Toulouse, France;","institution_ids":["https://openalex.org/I4210142058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044926442","display_name":"Hubert Lulka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Hubert Lulka","raw_affiliation_strings":["3INSERM, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3INSERM, Toulouse, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009439707","display_name":"Gilles Cambois","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142058","display_name":"InvivoGen (France)","ror":"https://ror.org/03fdne361","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210142058"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Gilles Cambois","raw_affiliation_strings":["2Cayla INVIVOGEN, Toulouse, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cayla INVIVOGEN, Toulouse, France;","institution_ids":["https://openalex.org/I4210142058"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Naima Hanoun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Naima Hanoun","raw_affiliation_strings":["3INSERM, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3INSERM, Toulouse, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087109575","display_name":"Fabian Gross","orcid":"https://orcid.org/0000-0002-0249-6404","observed_orcids":["https://orcid.org/0000-0002-0249-6404"]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fabian Gross","raw_affiliation_strings":["4CIC Biotherapie Toulouse Hospital, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4CIC Biotherapie Toulouse Hospital, Toulouse, France","institution_ids":["https://openalex.org/I3019448017"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071308757","display_name":"Jean-G\u00e9rard Tiraby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142058","display_name":"InvivoGen (France)","ror":"https://ror.org/03fdne361","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210142058"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean Tiraby","raw_affiliation_strings":["2Cayla INVIVOGEN, Toulouse, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cayla INVIVOGEN, Toulouse, France;","institution_ids":["https://openalex.org/I4210142058"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081053692","display_name":"Pierre Cordelier","orcid":"https://orcid.org/0000-0003-2096-7967","observed_orcids":["https://orcid.org/0000-0003-2096-7967"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pierre Cordelier","raw_affiliation_strings":["3INSERM, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3INSERM, Toulouse, France","institution_ids":["https://openalex.org/I154526488"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"8_Supplement","first_page":"3532A","last_page":"3532A"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9243000149726868,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9243000149726868,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.05220000073313713,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":0.9779999852180481},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.9480000138282776},{"id":"https://openalex.org/keywords/somatostatin-receptor-2","display_name":"somatostatin receptor 2","score":0.902999997138977},{"id":"https://openalex.org/keywords/nonviral-gene-delivery","display_name":"non-viral gene delivery","score":0.7929999828338623},{"id":"https://openalex.org/keywords/tumor-shrinkage","display_name":"tumor shrinkage","score":0.6930000185966492},{"id":"https://openalex.org/keywords/treatment-safety-and-feasibility","display_name":"treatment safety and feasibility","score":0.5440000295639038},{"id":"https://openalex.org/keywords/advanced-pancreatic-cancer","display_name":"advanced pancreatic cancer","score":0.6119999885559082},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7289999723434448}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.786309540271759},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7595921754837036},{"id":"https://openalex.org/C2777148230","wikidata":"https://www.wikidata.org/wiki/Q17144959","display_name":"FOLFIRINOX","level":5,"score":0.7180942296981812},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5553092360496521},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5503149628639221},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.549237847328186},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.46368828415870667},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.39370277523994446},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38844653964042664},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.33247166872024536},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.23461315035820007}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2013-3532a","doi":"https://doi.org/10.1158/1538-7445.am2013-3532a","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-3532a","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1591990851","https://openalex.org/W2026016363","https://openalex.org/W2378229487","https://openalex.org/W7150969917","https://openalex.org/W2360280907","https://openalex.org/W2316230393","https://openalex.org/W2622678622","https://openalex.org/W2091652182","https://openalex.org/W2174297637","https://openalex.org/W2265921034"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"the":[2,47,126,143,168,177,185,188,191,207,295,376,381],"median":[3,278],"survival":[4,32,276,279],"of":[5,50,128,142,170,190,217,240,358,375,380],"patients":[6,116,178,241,312],"diagnosed":[7],"with":[8,313],"locally":[9],"advanced":[10,314],"or":[11],"metastatic":[12],"pancreatic":[13,362],"adenocarcinoma":[14],"(PDA)":[15],"is":[16,173,307],"4":[17],"to":[18,44,71,75,77,132,206,321,367],"6":[19],"months.":[20,166],"Chemotherapies":[21],"(gemcitabine,":[22],"FOLFIRINOX)":[23],"and":[24,95,140,157,187,194,264,277,285,309],"molecular":[25],"targeted":[26],"therapies":[27],"only":[28],"offer":[29],"a":[30,100,329],"marginal":[31],"benefit.":[33],"Consequently,":[34],"we":[35,90,249,292,325],"developed":[36],"new":[37],"strategies":[38],"based":[39,333],"on":[40,86,334],"therapeutic":[41,323],"gene":[42,57,70,144,243,281,359],"transfer":[43],"help":[45],"alleviate":[46],"dismal":[48],"prognosis":[49],"PDA.":[51,315],"We":[52,66,211,230],"demonstrated":[53,250,293],"that":[54,213,232,298],"transferring":[55],"SSTR2":[56,94],"in":[58,81,107,110,125,184,221,227,237,254,260,267,311],"PDA":[59,105],"experimental":[60,365],"models":[61,366],"strongly":[62],"inhibited":[63],"tumor":[64,73,79,252,265],"progression.":[65],"generated":[67],"DCK::UMK":[68,96],"fusion":[69],"chemosensitize":[72],"cells":[74],"gemcitabine":[76,163],"provoke":[78],"shrinkage":[80,253],"immune":[82],"competent":[83],"animals.":[84],"Based":[85],"these":[87,272],"promising":[88],"results,":[89],"asked":[91],"whether":[92],"combining":[93],"genes":[97,301],"delivered":[98],"by":[99,305],"non-viral":[101,303],"vector":[102],"may":[103],"impede":[104],"growth":[106],"patients.":[108],"Methods:":[109],"this":[111,171,335],"first-in-man":[112],"clinical":[113,370],"trial,":[114],"22":[115],"(12":[117],"first":[118,246,296],"line,":[119],"10":[120],"second":[121],"line)":[122],"were":[123,148,179,209],"included":[124],"CHU":[127],"Toulouse":[129],"from":[130,364],"12/2010":[131],"9/2012.":[133],"Four":[134],"different":[135],"doses":[136],"(125,":[137],"250,":[138],"500":[139],"1000\u03bcg)":[141],"therapy":[145,282,360],"product":[146],"(GTP)":[147],"injected":[149,181],"twice":[150],"using":[151,302],"endoscopic":[152],"ultrasound":[153],"(EUS)":[154],"(day":[155],"1":[156,268],"day":[158],"28).":[159],"Patients":[160],"concomitantly":[161],"received":[162],"for":[164,294,361,384],"2":[165,255],"Results:":[167],"feasibility":[169],"approach":[172],"excellent,":[174],"as":[175],"all":[176,228,290],"successfully":[180],"despite":[182],"differences":[183],"site":[186],"size":[189],"primary":[192],"tumor,":[193],"pre-existing":[195],"treatments":[196],"(biliary":[197],"stent,":[198],"surgical":[199],"bypass).":[200],"No":[201],"serious":[202],"adverse":[203],"events":[204],"related":[205],"GTP":[208,218],"recorded.":[210],"found":[212,231],"less":[214],"than":[215],"0.001%":[216],"was":[219,225],"detected":[220],"blood,":[222],"while":[223],"urine":[224],"negative":[226],"cases.":[229],"CA":[233],"19.19":[234],"levels":[235],"decreased":[236],"68%":[238],"(15/22)":[239],"following":[242,280],"therapy.":[244],"In":[245,271],"line":[247],"patients,":[248,274],"partial":[251],"cases":[256,262],"(16%),":[257],"stable":[258],"disease":[259],"9":[261],"(75%),":[263],"progression":[266],"case":[269],"(8%).":[270],"latter":[273],"progression-free":[275],"reached":[283],"7":[284],"11.3":[286],"months,":[287],"respectively.":[288],"Conclusions:":[289],"together,":[291],"time":[297],"delivering":[299],"antitumoral":[300],"vectors":[304],"EUS":[306],"feasible":[308],"safe":[310],"As":[316],"our":[317],"preliminary":[318],"results":[319],"tend":[320],"demonstrate":[322],"efficacy,":[324],"are":[326],"currently":[327],"designing":[328],"phase":[330,368],"II":[331],"trial":[332],"approach.":[336],"Citation":[337],"Format:":[338],"Louis":[339],"Buscail,":[340],"Barbara":[341],"Bournet,":[342],"Fabienne":[343],"Vernejoul,":[344],"Hubert":[345],"Lulka,":[346],"Gilles":[347],"Cambois,":[348],"Naima":[349],"Hanoun,":[350],"Fabian":[351],"Gross,":[352],"Jean":[353],"Tiraby,":[354],"Pierre":[355],"Cordelier.":[356],"Development":[357],"carcinoma:":[363],"I":[369],"trial.":[371],"[abstract].":[372],"In:":[373],"Proceedings":[374],"104th":[377],"Annual":[378],"Meeting":[379],"American":[382],"Association":[383],"Cancer":[385,395],"Research;":[386],"2013":[387],"Apr":[388],"6-10;":[389],"Washington,":[390],"DC.":[391],"Philadelphia":[392],"(PA):":[393],"AACR;":[394],"Res":[396],"2013;73(8":[397],"Suppl):Abstract":[398],"nr":[399],"3532A.":[400],"doi:10.1158/1538-7445.AM2013-3532A":[401]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}